Hypothyroidism (Underactive Thyroid) Treatment Guide

What Is Hypothyroidism?

The thyroid gland — a butterfly-shaped structure at the front of the neck — produces two hormones, thyroxine (T4) and triiodothyronine (T3), that regulate metabolism across virtually every organ system. Hypothyroidism occurs when the thyroid produces less hormone than the body requires.

It is one of the most common endocrine conditions in the United States, affecting roughly 5% of the population. Women are diagnosed far more often than men, and prevalence increases with age. Many patients — particularly in early disease — are unaware they have it because the symptoms develop slowly and overlap significantly with other conditions.

The term "underactive thyroid" covers a spectrum. Overt hypothyroidism means clearly low thyroid hormone levels with an elevated TSH (the pituitary's signal demanding more hormone). Subclinical hypothyroidism means the TSH is mildly elevated but thyroid hormone levels remain within the reference range — the gland is struggling but compensating. Both have implications for treatment decisions.

Causes: Why the Thyroid Slows Down

Hypothyroidism has several causes, with Hashimoto's thyroiditis at the top of the list.

Hashimoto's Thyroiditis

Hashimoto's thyroiditis is an autoimmune condition in which the immune system mistakenly targets and destroys thyroid tissue. It is the most common cause of hypothyroidism in countries where iodized salt is widely available, including the United States.^[6] The immune system produces antibodies — most notably thyroid peroxidase antibodies (TPO-Ab) — that progressively damage hormone-producing cells.

The destruction does not happen overnight. Patients may spend years in a phase of fluctuating thyroid function before developing overt hypothyroidism. Some experience a temporary period of mild hyperthyroidism ("Hashitoxicosis") early in the disease, caused by the release of stored hormone from damaged cells. TPO antibody testing is used to confirm autoimmune disease as the underlying cause.

Hashimoto's runs in families and is associated with other autoimmune conditions — including type 1 diabetes, rheumatoid arthritis, and Sjögren's syndrome.^[7] If you have one autoimmune disease, thyroid screening is worth discussing with your physician.

Other Common Causes

• Thyroid surgery: Partial or complete removal of the thyroid (thyroidectomy) reduces or eliminates hormone production. Patients undergoing total thyroidectomy require full thyroid hormone replacement for life.
• Radioactive iodine (RAI) therapy: Used to treat hyperthyroidism or thyroid cancer, RAI often causes permanent hypothyroidism as a predictable consequence.
• Medications: Lithium, amiodarone, interferon, and certain checkpoint inhibitors used in cancer treatment can all impair thyroid function.
• Pituitary disease (central hypothyroidism): Less common. A damaged or malfunctioning pituitary gland fails to produce enough TSH, leaving the thyroid gland with no signal to produce hormone.
• Iodine deficiency: The dominant cause of hypothyroidism worldwide, though rare in the U.S. due to iodized salt.

Symptoms: Why Hypothyroidism Gets Missed

Thyroid hormone acts as a metabolic accelerator for most body systems. When levels are low, everything slows down — sometimes so gradually that patients adapt without realizing something is wrong.

The most common symptoms are fatigue, unexplained weight gain, cold intolerance, constipation, dry skin, coarse or thinning hair, brittle nails, and slowed reflexes. Cognitive symptoms — difficulty concentrating, memory lapses, a general mental fogginess — are among the most disruptive to daily life and among the hardest for patients to describe.

Physical examination findings include bradycardia (slow heart rate), delayed relaxation of deep tendon reflexes, puffy face and periorbital edema, a hoarse voice, and goiter in some patients. These are more prominent in overt, long-standing hypothyroidism than in early or subclinical disease.

Diagnosis and TSH Interpretation

Diagnosis starts with a serum TSH (thyroid-stimulating hormone) level. TSH is produced by the pituitary gland to signal the thyroid to produce hormone. When thyroid output is low, the pituitary compensates by producing more TSH — so an elevated TSH is the earliest and most sensitive indicator of a struggling thyroid, often rising before T4 levels fall out of the reference range.

Free T4 (FT4) is ordered alongside TSH in selected situations — particularly when TSH is very high, when central hypothyroidism is suspected (where TSH may be low or normal despite insufficient thyroid hormone), or when patients remain symptomatic despite normal TSH on treatment. T3 levels are not routinely helpful for initial diagnosis.

TPO antibody testing confirms autoimmune thyroid disease as the cause and helps predict progression. A patient with subclinical hypothyroidism who is TPO antibody positive has roughly a two-fold greater risk of progressing to overt hypothyroidism, and this positive status shifts the treatment decision toward earlier intervention.^[5]

Levothyroxine: First-Line Treatment

Levothyroxine (brand names: Synthroid, Levoxyl, Tirosint, Unithroid) is the standard treatment for hypothyroidism. The ATA 2014 guidelines give this a strong recommendation backed by decades of clinical experience and consistent efficacy data.^[1] It is a synthetic form of T4 — the same hormone your thyroid produces — that is converted by the body's tissues into the active T3 form.

Dosing

The full replacement dose for most healthy adults with primary hypothyroidism is 1.6 mcg/kg per day.^[2] For a 70 kg (154 lb) adult, that is approximately 112 mcg daily. In practice, dose requirements vary based on body weight, residual thyroid function, the underlying cause of hypothyroidism, and individual absorption differences.

For older adults (over 65), patients with known coronary artery disease, and anyone with long-standing untreated hypothyroidism, the starting dose should be much lower — typically 25 to 50 mcg — with gradual upward titration every 6 to 8 weeks. Starting a depleted cardiovascular system at full replacement dose can precipitate arrhythmias or angina.^[3]

Dose adjustments after the initial titration are made in 12.5 to 25 mcg increments, following TSH rechecks 6 to 8 weeks after each change. Once the TSH is stable and within the target range, annual monitoring is sufficient in most patients — though any significant change in body weight, concurrent illness, new medication, or clinical symptoms warrants earlier reassessment.^[3]

Brand vs. Generic: The Bioequivalence Debate

Both brand-name Synthroid and generic levothyroxine are FDA-approved and considered bioequivalent. For most patients, either works well. The clinical concern arises when patients switch between formulations — brand to generic, one generic manufacturer to another — which can cause small but detectable fluctuations in TSH.

The ATA has noted that patients who are well-controlled on one formulation should ideally stay on that formulation. If a switch occurs (often due to insurance or pharmacy changes), a TSH recheck in 6 to 8 weeks is a reasonable precaution. The concern is most clinically relevant in pregnant women, patients with thyroid cancer (where precise TSH suppression targets matter), and elderly patients where small fluctuations carry greater risk.

How and When to Take It

Levothyroxine absorption is maximized — approximately 75% of the administered dose — when taken on an empty stomach.^[4] The standard instruction is to take it 30 to 60 minutes before breakfast with a full glass of water. Some patients find it easier to take at bedtime, which has been shown in some studies to produce slightly better TSH control — provided the stomach has been empty for at least 3 to 4 hours.

Medication Interactions That Matter

Several common medications and supplements significantly reduce levothyroxine absorption. Missing this information leads to undertreatment — patients take their levothyroxine faithfully but never reach an adequate level because something is blocking it.

In my experience, the most common reason a patient's TSH remains stubbornly elevated despite good adherence is one of these interactions — usually calcium taken at breakfast or a PPI taken at the same time as levothyroxine. A thorough medication review, including supplements, often solves what appears to be a dosing problem.

Subclinical Hypothyroidism: When to Treat and When to Watch

Subclinical hypothyroidism — defined as a TSH between approximately 4.5 and 10 mIU/L with normal free T4 — affects roughly 3–8% of the general population and is substantially more common in older adults and women.^[5] The central clinical question is always: does this patient benefit from treatment, or will treatment add risk without meaningful benefit?

Current ATA and AACE guidelines recommend treatment when TSH exceeds 10 mIU/L in patients age 70 or younger without significant cardiovascular disease.^[5] For mild elevation (TSH 4.5–10), the decision is individualized based on:^[3]

• Symptoms: Classic hypothyroid symptoms (fatigue, weight gain, cold intolerance, cognitive slowing) that correlate with the TSH elevation argue for a treatment trial.
• TPO antibody status: A positive result indicates autoimmune thyroiditis and roughly doubles the annual rate of progression to overt hypothyroidism, making treatment more defensible.
• Cardiovascular risk: Subclinical hypothyroidism in younger patients has been associated with adverse lipid profiles and increased cardiac risk in some studies, which can tip the decision toward treatment.
• Age: In adults over 70, evidence for benefit is weaker and risks of over-treatment (atrial fibrillation, bone loss) are greater. Treatment in this age group is not routinely recommended unless TSH is substantially elevated or symptoms are severe.
• Pregnancy: Different rules apply. TSH targets tighten significantly during pregnancy (see below).

Alternative Thyroid Therapies: T4/T3 Combination and Desiccated Thyroid

Most patients do well on levothyroxine alone. But 5 to 15% of patients on adequate levothyroxine with a normal TSH continue to report symptoms — fatigue, brain fog, weight difficulty — that they feel are unresolved.^[9] This has driven sustained interest in alternative thyroid hormone formulations.

Combination T4/T3 Therapy (Levothyroxine + Liothyronine)

Adding liothyronine (synthetic T3, brand name Cytomel) to levothyroxine directly provides both thyroid hormones, mimicking what a healthy thyroid would normally secrete. The rationale is that some patients — particularly those with certain gene variants in the deiodinase enzyme that converts T4 to T3 — may not efficiently convert levothyroxine to adequate T3 in tissues despite a normal TSH.^[9]

The ATA 2014 guidelines concluded that there is no consistent evidence of superiority of T4/T3 combination therapy over levothyroxine alone at the population level.^[1] Multiple randomized trials have not demonstrated reliable improvements in quality of life, mood, or cognitive function. That said, both the ATA and the European Thyroid Association acknowledge that a supervised trial may be reasonable in patients who remain persistently symptomatic despite optimized levothyroxine therapy and a confirmed normal TSH, after ruling out other causes of their symptoms.

Liothyronine has a short half-life (about one day, compared to about one week for levothyroxine), which can cause fluctuating T3 levels throughout the day, including peaks that carry a small risk of cardiovascular side effects. Sustained-release liothyronine formulations are under investigation to address this limitation.

Desiccated Thyroid Extract (Armour Thyroid)

Desiccated thyroid extract (DTE), derived from dried porcine (pig) thyroid gland, contains both T4 and T3 in a fixed ratio. Armour Thyroid is the most recognized brand. DTE predates synthetic levothyroxine and was the only available thyroid replacement for decades.

Patient preference data is interesting: in a crossover trial of 70 patients, 49% preferred DTE over levothyroxine, and DTE use was associated with modest weight loss — though there were no statistically significant differences in symptoms or psychometric testing.^[10] A retrospective study of 250 patients found that those who switched to Armour Thyroid reported significantly less fatigue and weight gain while euthyroid.^[11]

The clinical concern with DTE is batch-to-batch variability — the T4:T3 ratio can differ slightly between lots, which can make precise TSH management harder. The fixed T4:T3 ratio also does not reflect normal human thyroid hormone physiology. For these reasons, current guidelines position DTE as a second-line option rather than a first choice, considered in patients who remain symptomatic on levothyroxine after other explanations are excluded.

Hypothyroidism and Pregnancy

Pregnancy significantly increases thyroid hormone demand. The growing placenta and fetus require thyroid hormone — fetal thyroid function does not fully develop until mid-pregnancy, so the mother's thyroid must supply both. Renal clearance of iodine also increases, and elevated estrogen raises thyroxine-binding globulin levels, further increasing the demand for T4 production.

For women with existing hypothyroidism on levothyroxine, the dose typically needs to increase by 25 to 30% immediately upon confirmed pregnancy — the practical approach is to increase from 7 to 9 doses per week (essentially adding two extra doses per week) when the pregnancy is confirmed, rather than waiting for the first prenatal TSH result.^[3]

Untreated or inadequately treated hypothyroidism during pregnancy is associated with miscarriage, placental abruption, preterm labor, gestational hypertension, and impaired fetal brain development. These outcomes make thyroid management one of the highest-priority aspects of prenatal care for women with known thyroid disease.

Women with Hashimoto's who are euthyroid (normal TSH) before pregnancy should also have their TSH checked early — ideally before 8 weeks — because the autoimmune disease and the hormonal demands of pregnancy can push a previously compensated thyroid into an underactive state.

Myxedema Coma: The Extreme End

Myxedema coma — more accurately called myxedema crisis — is a rare, life-threatening complication of severe, prolonged hypothyroidism. Despite the name, actual coma is not always present; altered mental status, profound lethargy, and organ dysfunction are the hallmarks.^[12]

It typically affects older adults with undiagnosed or poorly managed hypothyroidism and is triggered by a physiologic stressor — pneumonia, surgery, cold exposure, trauma, or medications like sedatives, lithium, or amiodarone. The body's already-depleted reserves of thyroid hormone cannot meet even baseline metabolic demands.

The preventive message is straightforward: consistent thyroid medication management prevents myxedema crisis from happening. Patients who take their levothyroxine reliably and maintain routine TSH monitoring are extremely unlikely to reach this point.

Managing Thyroid Disease Through Telehealth

For patients with established hypothyroidism on a stable levothyroxine dose, the ongoing management is largely lab-driven — review TSH results, adjust dose if needed, and refill prescription. This workflow fits telehealth exceptionally well.

Telehealth visits for thyroid management work like this: you have TSH (and free T4 if indicated) drawn at a local lab. Your physician reviews the results remotely, assesses any symptoms you report, and either confirms the current dose or adjusts it — all without requiring you to take time off work for an in-person visit.

Telehealth is appropriate for the large majority of hypothyroid patients. The situations that typically require in-person evaluation include physical examination findings (a suspected goiter, a palpable thyroid nodule, or signs of myxedema), difficulty managing hypothyroidism during pregnancy requiring close obstetric coordination, or a newly diagnosed condition where establishing care in person makes sense.

What I tell patients is this: once your dose is stable and your TSH is in range, there is no clinical reason your ongoing thyroid care cannot happen from home. Regular monitoring — not regular in-person visits — is what keeps thyroid disease controlled.

Frequently Asked Questions